Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Site-specific protein modifications are vital for biopharmaceutical drug development. Gluconoylation is a non-enzymatic, post-translational modification of N-terminal HisTags. We report high-yield, site-selective in vitro α-aminoacylation of peptides, glycoproteins, antibodies, and virus-like particles (VLPs) with azidogluconolactone at pH 7.5 in 1 h. Conjugates slowly hydrolyse, but diol-masking with borate esters inhibits reversibility. In an example, we multimerise azidogluconoylated SARS-CoV-2 receptor-binding domain (RBD) onto VLPs via click-chemistry, to give a COVID-19 vaccine. Compared to yeast antigen, HEK-derived RBD was immunologically superior, likely due to observed differences in glycosylation. We show the benefits of ordered over randomly oriented multimeric antigen display, by demonstrating single-shot seroconversion and best virus-neutralizing antibodies. Azidogluconoylation is simple, fast and robust chemistry, and should accelerate research and development.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cbic.202100381 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pyridoxamine promotes heat-induced protein modifications in whey as evaluated by structure- and binding site-specific profiling using high-performance liquid chromatography-tandem mass spectrometry in scheduled multiple reaction mode.
Food Chem
August 2025
Food Chemistry, Department of Chemistry and Pharmacy, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany; FAU NeW - Research Center New Bioactive Compounds, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Nikolaus-Fiebiger-Str. 10
Thermal processing of whey-based foods leads to nonenzymatic post-translational protein modifications (nePTMs), which reduce the protein quality. Because pyridoxamine inhibits protein glycation and oxidation in vivo and in model reactions, the present study investigated the effect of pyridoxamine on β-lactoglobulin modifications in heated whey. After Glu-C digestion, 14 nePTMs were quantified at 29 binding sites by micro-liquid chromatography-electrospray ionization-tandem mass spectrometry in scheduled multiple reaction monitoring mode.
View Article and Find Full Text PDFGolgi_traff phylogeny reveals ancient eukaryotic genes with recent surprises: replication and diversification of HID1 domain-containing protein unique to Schizosaccharomyces.
FEMS Microbiol Lett
January 2025
North West Cancer Research Institute, Bangor University, Bangor, Gwynedd LL57 2DG, United Kingdom.
Golgi_traff is a Pfam clan containing two members, Dymeclin (DYM) and HID1 domain-containing protein (HID). Interrogation of over 900 eukaryotic genomes with sequence models showed that both are ancient eukaryotic genes, which have exhibited different paths of gene loss, including from major taxonomic groups. For example, the Metazoa have both genes, whereas the Viridiplantae and Dikarya have lost HID and DYM, respectively.
View Article and Find Full Text PDFATE1 promotes breast cancer progression via arginylation-dependent regulation of MAPK-MYC signaling.
Cell Commun Signal
September 2025
Nucleic Acid Therapeutics Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Background: Arginyl-tRNA-protein transferase (ATE1) catalyzes N-terminal arginylation, a regulatory protein modification implicated in various cellular processes, including proliferation, apoptosis, and migration. Although ATE1 has context-dependent roles in cancer, its specific function in breast cancer remains unclear. This study investigates the oncogenic role of ATE1 across multiple breast cancer subtypes and its underlying molecular mechanisms.
View Article and Find Full Text PDFEnhancing the thermal stability of Xylanase HWxyn11 through N-terminal substitution and C-terminal carbohydrate binding module fusion.
Int J Biol Macromol
August 2025
School of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China; State Key Laboratory of Pulp and Paper Engineering, South China University of Technology, Guangzhou 510640, China; Guangdong Youmei Institute of Intelligent Bio-manufacturing Co., Ltd, Foshan 52820
Xylanases from glycoside hydrolases family 11 (GH11) are widely used due to their substrate selectivity and broad optimal pH range. With the increasing demands in industrial production, the development of xylanases with multiple stress resistances and high thermostability has become a research focus. We heterologously expressed and characterized a novel GH11 xylanase (HWxyn11) from Hortaea werneckii.
View Article and Find Full Text PDFEffects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trial.
Nat Med
August 2025
Eli Lilly and Company, Indianapolis, IN, USA.
Relaxin is a peptide hormone that may decrease circulatory congestion and improve kidney function. In this study, we conducted a double-blind, international, multicenter trial to test whether volenrelaxin, a long-acting form of human relaxin, can improve left atrial (LA) function, reduce congestion and improve kidney function in patients with heart failure and preserved ejection fraction (HFpEF). We randomly assigned patients with New York Heart Association (NYHA) class II-IV HFpEF and recent heart failure (HF) decompensation to 25-mg, 50-mg or 100-mg volenrelaxin or placebo administered subcutaneously once weekly.
View Article and Find Full Text PDF